Content area



Lars H. Pinborg1, 2, Bo Jespersen3, Sándor Beniczky4, Martin Fabricius5, Gyoergy Rasonyi5, Peter W. Uldall6, 7, Ioannis Tsiropoulos1, Anne-Mette Leffers8, Camilla Gøbel Madsen8, Mette Trane Foged2, Morten Ziebell2, 3, Otto M. Henriksen9, Martin B. Jørgensen10, Kirsten Vinter1, Louise Stauning11, Helle Broholm12, Jannick Brennum3, Anne Sabers1 & Guido Rubboli11 1) Neurologisk Klinik, Rigshospitalet 2) Neurobiologisk Forskningsenhed, Rigshospitalet 3) Neurokirurgisk Klinik, Rigshospitalet 4) Klinisk Neurofysiologisk Klinik, Epilepsihospitalet i Dianalund 5) Klinisk Neurofysiologisk klinik, Rigshospitalet 6) Pædiatrisk Klinik, Rigshospitalet 7) Epilepsihospitalet i Dianalund 8) MR-afdelingen, Hvidovre Hospital 9) PET og Nuklearmedicinsk Klinik, Rigshospitalet 10) Psykiatrisk Center København 11) Neurologisk Klinik, Epilepsihospitalet i Dianalund 12) Patologiafdelingen, Rigshospitalet Ugeskr Læger 2018;180:V09170653
Ugeskr Læger 2018;180:V09170653
Blad nummer: 
Epilepsy surgery
Surgery is the only treatment option with the potential to cure epilepsy. This review is a description of the multidisciplinary and multimodal presurgical evaluation process and the outcome of the Danish epilepsy surgery programme. The outcome aligns with international results and serious complications to surgery are very rare. The annual number of operations per capita compares to neighbouring countries and is equally distributed across Denmark. In accordance with international recommendations, Danish drug-resistant patients should be referred to epilepsy surgery evaluation at an early stage of the disease.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Eva Bjerre Søndergaard | 30/11
4 kommentarer
af Ulla Hørding | 30/11
2 kommentarer
af Hans Petter Hougen | 29/11
2 kommentarer
af Thorkil Poulsen | 29/11
1 Kommentar
af Erik Sloth | 22/11
1 Kommentar
af Frank Bang Nissen | 21/11
3 kommentarer